News - Aspen Pharmacare

Filter

Current filters:

Aspen Pharmacare

Popular Filters

GlaxoSmithKline agrees £700 million deal with Aspen

GlaxoSmithKline agrees £700 million deal with Aspen

30-09-2013

GlaxoSmithKline says it has now reached agreement to sell its thrombosis brands, Arixtra and Fraxiparine,…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalRest of the World

Aspen Pharma reports rise in profits from new product launches

11-09-2013

South Africa's leading drugmaker Aspen Pharmacare (APN: SJ) has released financial results which show…

ArixtraAspen PharmacareFinancialFraxiparineGlaxoSmithKlineMerck & CoPharmaceuticalRest of the World

Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site

19-06-2013

UK pharma giant GlaxoSmithKline (LSE: GSK) said yesterday (June 18) that it has received an offer for…

ArixtraAspen PharmacareCardio-vascularFraxiparineGlaxoSmithKlineMergers & AcquisitionsPharmaceuticalProduction

South Africa's drugmakers bemoan low medicine price hikes

27-01-2013

South Africa's Department of Health announced last week that pharmaceutical companies will be allowed…

Adcock IngramAspen PharmacareGenericsPharmaceuticalPricingRest of the World

Aspen Pharmacare acquires portfolio from GSK in Australia for £172 million

15-08-2012

South Africa headquartered Aspen Pharmacare (APN: SJ) revealed this morning that it has reached agreement…

Asia-PacificAspen PharmacareGlaxoSmithKlineMergers & AcquisitionsPharmaceutical

Aspen and Adcock win South Africa preference tender

14-08-2012

South Africa's Department of Health last week awarded its first oral solid dosage (OSD) tender aligned…

Adcock IngramAspen PharmacareFinancialGenericsProductionRest of the World

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top